Dyadic International Future Growth
Future criteria checks 2/6
Dyadic International's earnings are forecast to decline at 60.4% per annum while its annual revenue is expected to grow at 36.4% per year. EPS is expected to decline by 55.4% per annum.
Key information
-60.4%
Earnings growth rate
-55.4%
EPS growth rate
Biotechs earnings growth | 20.6% |
Revenue growth rate | 36.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 01 Apr 2024 |
Recent future growth updates
Recent updates
Is Dyadic International (NASDAQ:DYAI) In A Good Position To Deliver On Growth Plans?
Mar 14Is Dyadic International (NASDAQ:DYAI) In A Good Position To Invest In Growth?
Oct 28Here's Why We're Watching Dyadic International's (NASDAQ:DYAI) Cash Burn Situation
Jun 21We're Hopeful That Dyadic International (NASDAQ:DYAI) Will Use Its Cash Wisely
Oct 05Dyadic collaborates with Syngene International to develop a COVID-19 vaccine candidate
May 26We're Not Very Worried About Dyadic International's (NASDAQ:DYAI) Cash Burn Rate
May 03Dyadic International's (NASDAQ:DYAI) Wonderful 318% Share Price Increase Shows How Capitalism Can Build Wealth
Feb 22Dyadic International (NASDAQ:DYAI) Is In A Good Position To Deliver On Growth Plans
Jan 18Do Insiders Own Lots Of Shares In Dyadic International, Inc. (NASDAQ:DYAI)?
Dec 10Dyadic International reports Q3 results
Nov 12Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 6 | -31 | N/A | N/A | 1 |
12/31/2024 | 4 | -23 | N/A | N/A | 1 |
12/31/2023 | 3 | -7 | -7 | -7 | N/A |
9/30/2023 | 3 | -7 | -7 | -7 | N/A |
6/30/2023 | 3 | -7 | -7 | -7 | N/A |
3/31/2023 | 3 | -8 | -7 | -7 | N/A |
12/31/2022 | 3 | -10 | -8 | -8 | N/A |
9/30/2022 | 2 | -12 | -9 | -9 | N/A |
6/30/2022 | 2 | -12 | -12 | -12 | N/A |
3/31/2022 | 3 | -12 | -12 | -12 | N/A |
12/31/2021 | 2 | -13 | -11 | -11 | N/A |
9/30/2021 | 2 | -11 | -10 | -10 | N/A |
6/30/2021 | 2 | -12 | -7 | -7 | N/A |
3/31/2021 | 2 | -10 | -6 | -6 | N/A |
12/31/2020 | 2 | -9 | -7 | -7 | N/A |
9/30/2020 | 2 | -9 | -7 | -7 | N/A |
6/30/2020 | 2 | -8 | -7 | -7 | N/A |
3/31/2020 | 2 | -8 | -6 | -6 | N/A |
12/31/2019 | 2 | -8 | -6 | -6 | N/A |
9/30/2019 | 2 | -7 | -6 | -6 | N/A |
6/30/2019 | 2 | -7 | -5 | -5 | N/A |
3/31/2019 | 2 | -6 | -5 | -5 | N/A |
12/31/2018 | 1 | -6 | -4 | -4 | N/A |
9/30/2018 | 1 | -7 | -4 | -4 | N/A |
6/30/2018 | 1 | -7 | -5 | -5 | N/A |
3/31/2018 | 1 | -6 | -2 | -2 | N/A |
12/31/2017 | 1 | -2 | -2 | -2 | N/A |
9/30/2017 | 1 | -3 | N/A | -2 | N/A |
6/30/2017 | 1 | -2 | N/A | -5 | N/A |
3/31/2017 | 1 | -1 | N/A | -5 | N/A |
12/31/2016 | 1 | -4 | N/A | -6 | N/A |
9/30/2016 | 0 | -2 | N/A | -7 | N/A |
6/30/2016 | 0 | 0 | N/A | -2 | N/A |
3/31/2016 | 0 | -2 | N/A | -2 | N/A |
12/31/2015 | 0 | -1 | N/A | -1 | N/A |
9/30/2015 | 0 | -2 | N/A | 1 | N/A |
6/30/2015 | -6 | -4 | N/A | -1 | N/A |
3/31/2015 | -3 | -5 | N/A | -5 | N/A |
12/31/2014 | 0 | -5 | N/A | -6 | N/A |
9/30/2014 | 4 | -5 | N/A | -5 | N/A |
6/30/2014 | 14 | -6 | N/A | -2 | N/A |
3/31/2014 | 18 | -1 | N/A | 3 | N/A |
12/31/2013 | 17 | 0 | N/A | 5 | N/A |
9/30/2013 | 16 | -1 | N/A | 6 | N/A |
6/30/2013 | 15 | 0 | N/A | 5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DYAI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: DYAI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: DYAI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: DYAI's revenue (36.4% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: DYAI's revenue (36.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DYAI's Return on Equity is forecast to be high in 3 years time